AstraZeneca and CICC Launch $1 Billion Healthcare Industry Investment Fund

According to new reports from Reuters and other foreign media, AstraZeneca will partner with China International Capital Corporation (CICC) to invest $1 billion in establishing a healthcare industry investment fund aimed at expanding research and development efforts in China's healthcare sector.

The fund will be used to invest in enterprises in China, including those located in the AstraZeneca Wuxi International Life Science Innovation Park.